Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.

Blood - 15 Mar 2012

Yokoyama Takashi, Toki Tsutomu, Aoki Yoshihiro, Kanezaki Rika, Park Myoung-Ja, Kanno Yohei, Takahara Tomoko, Yamazaki Yukari, Ito Etsuro, Hayashi Yasuhide, Nakamura Takuro

Abstract excerpt

Trib1 has been identified as a myeloid oncogene in a murine leukemia model. Here we identified a TRIB1 somatic mutation in a human case of Down syndrome-related acute megakaryocytic leukemia. The mutation was observed at well-conserved arginine 107 residue in the pseudokinase domain. This R107L m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to CCAAT-Enhancer-Binding Protein-alpha
Share to Down Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Extracellular Signal-Regulated MAP Kinases

Share to Immunoblotting

Share to Leukemia, Megakaryoblastic, Acute

Share to Oncogenes

Share to Real-Time Polymerase Chain Reaction

Source

Identifiers

PMID: 22294728
DOI: 10.1182/blood-2010-12-324806

Genes

TRIB1
GATA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22294728-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.PMID 22294728Read ↗

A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.Semantic proximity Read ↗

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

[The role of GATA1 mutation in acute megakaryocytic leukemia].Semantic proximity Read ↗

Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformationSemantic proximity Read ↗

Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.Semantic proximity Read ↗

Autopsy case of a stillbirth with transient abnormal myelopoiesis associated with Down syndrome: Immunohistochemical demonstration of GATA1 mutation in placental tissues.Semantic proximity Read ↗

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.Semantic proximity Read ↗

Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.Semantic proximity Read ↗

Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.Semantic proximity Read ↗

GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.